Related Experiment Videos
Cerebrovascular Disease in Pregnancy
Michael A. Sloan1, Barney J. Stern
1Center for Stroke Research, Department of Neurological Sciences, Rush Medical College, 1645 West Jackson Boulevard, Suite 400, Chicago, IL 60612, USA. michael_a_sloan@rush.edu
Current Treatment Options in Neurology
|August 5, 2003
Summary
Stroke during pregnancy, though rare, has varied causes impacting mother and fetus. Management requires individualized approaches for stroke, hemorrhage, and vascular malformations, with specific antithrombotic agents considered.
Area of Science:
- Neurology
- Obstetrics
- Maternal-Fetal Medicine
Background:
- Stroke in pregnancy is a distinct clinical entity affecting young women.
- Causes are diverse, including pregnancy-specific conditions like pre-eclampsia and eclampsia.
- While absolute risk is low, maternal and fetal outcomes can be significantly impacted.
Purpose of the Study:
- To review the causes, diagnosis, and management of stroke during pregnancy.
- To highlight the importance of considering non-eclampsia related causes of stroke.
- To provide guidance on the use of antithrombotic agents and management of cerebrovascular lesions.
Main Methods:
- Literature review of stroke in pregnancy, focusing on etiology, treatment, and outcomes.
- Analysis of current guidelines and evidence for managing ischemic and hemorrhagic stroke.
- Discussion of treatment options for aneurysms and arteriovenous malformations in pregnant patients.
Main Results:
- Severe pre-eclampsia and eclampsia are common, but not the only causes of stroke.
- Magnesium sulfate is recommended for eclampsia prevention.
- Low-dose aspirin, unfractionated heparin, and low molecular weight heparin are preferred antithrombotics for ischemic stroke, with LMWH potentially safer.
- Hemorrhagic stroke and vascular malformations require individualized, multimodal treatment strategies.
Conclusions:
- Stroke in pregnancy necessitates a comprehensive approach, considering both maternal and fetal well-being.
- Management strategies for different stroke types and vascular lesions must be tailored to the individual patient.
- Further research is needed due to the lack of randomized clinical trials in this population.